| Income Statement |
| Total Revenue | 190.17M |
|
| Revenues (USD) | 190.17M |
| Cost of Revenue | 73.80M |
| Gross Profit | 116.37M |
| Operating Expenses | 111.99M |
| Research and Development Expense | 28.41M |
| Selling, General and Administrative Expense | 83.59M |
| Operating Income | 4.38M |
| Interest Expense | 4.18M |
| Income Tax Expense | 992.00K |
| Net Income | -1.20M |
| Net Income Common Stock | -1.20M |
| Net Income Common Stock (USD) | -1.20M |
| Consolidated Income | -1.20M |
| Earnings per Basic Share | -0.01 |
| Earnings per Basic Share (USD) | -0.01 |
| Earnings per Diluted Share | -0.01 |
| Earning Before Interest & Taxes (EBIT) | 3.97M |
| Earning Before Interest & Taxes (USD) | 3.97M |
| Weighted Average Shares | 141.97M |
| Weighted Average Shares Diluted | 141.97M |
| Balance Sheet |
| Cash and Equivalents | 92.30M |
| Cash and Equivalents (USD) | 92.30M |
| Trade and Non-Trade Receivables | 70.43M |
| Current Assets | 223.71M |
| Property, Plant & Equipment Net | 72.74M |
| Total Assets | 672.81M |
| Debt Current | 47.97M |
| Total Debt | 357.52M |
| Current Liabilities | 213.49M |
| Debt Non-Current | 309.55M |
| Total Liabilities | 524.99M |
| Accumulated Retained Earnings (Deficit) | -887.27M |
| Accumulated Other Comprehensive Income | -6.10M |
| Shareholders Equity | 147.82M |
| Shareholders Equity (USD) | 147.82M |
| Assets Non-Current | 449.09M |
| Total Debt (USD) | 357.52M |
| Deferred Revenue | 35.58M |
| Goodwill and Intangible Assets | 330.18M |
| Liabilities Non-Current | 311.50M |
| Trade and Non-Trade Payables | 38.12M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 8.10M |
| Net Cash Flow from Financing | -16.18M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.66M |
| Capital Expenditure | -2.92M |
| Issuance (Repayment) of Debt Securities | -14.50M |
| Net Cash Flow from Investing | -3.15M |
| Net Cash Flow from Operations | 17.03M |
| Effect of Exchange Rate Changes on Cash | -362.00K |
| Share Based Compensation | 4.06M |